Atorvastatin on smoking in patients with chronic pulmonary heart disease events of recent cardiopulmonary.docVIP

 PAGE \* MERGEFORMAT 15 Atorvastatin on smoking in patients with chronic pulmonary heart disease events of recent cardiopulmonary Of: Zhangxiu Wei Zhu Ying Yang Jian Zhang Yuqing [Abstract] Objective To evaluate the effects of smoking atorvastatin with chronic pulmonary heart disease, recent cardiovascular events in patients. Methods 55 cases of smokers with chronic obstructive pulmonary disease (COPD associated with chronic pulmonary heart disease, pulmonary hypertension were randomly divided into atorvastatin treatment group (n = 27) and the conventional therapy group (n = 28). All patients received conventional treatment, atorvastatin treatment group were treated with atorvastatin (20 mg / d. Outlook Chae Tuo, respectively atorvastatin treatment group and routine treatment group before treatment, 6 months after the lung function, echocardiography, and 6 min walking distance of the changes, and follow-up of patients with recent cardiovascular events. the result of atorvastatin treatment group after 6 months Treatment of pulmonary arterial pressure before and earlier than the conventional treatment group over the same period decreased significantly (P lt;0.05), 6 min walk distance increased significantly (P lt;0.05), forced expiratory volume in 1 second (FEV1, FEV1 / forced vital capacity (FVC and other lung function indicator than the conventional treatment group had significant improvement after 6 months (P lt;0.05), conventional treatment group before treatment, after 6 months the difference was not statistically significant indicator (Pgt; 0.05), atorvastatin treatment group recently cardiopulmonary event rate was significantly lower than the conventional therapy group (P lt;0.05). Conclusion atorvastatin can improve smoking in patients with chronic pulmonary heart disease quality of life and lung function, reduce pulmonary artery pressure and improve the prognosis of patients. [Keywords:] atorvastatin, chronic obstructive pulmonary disease, chron